Publications:

An EGFR L858R mutation identified in 1862 Chinese NSCLC patients can be a promising neoantigen vaccine therapeutic strategy.

Frontiers In Immunology

Lin, Jing J; Liu, Jun J; Hao, Shi-Guang SG; Lan, Bin B; Zheng, Xiao-Bin XB; Xiong, Jia-Ni JN; Zhang, Ying-Qian YQ; Gao, Xuan X; Chen, Chuan-Ben CB; Chen, Ling L; Huang, Yu-Fang YF; Luo, Hong H; Yi, Yu-Ting YT; Yi, Xin X; Lu, Jian-Ping JP; Zheng, Xiong-Wei XW; Chen, Gang G; Wang, Xue-Feng XF; Chen, Yu Y

Publication Date: 2022

Variant appearance in text: RUNX2: 686G>T; R229M

PubMed Link: 36505399

Variant Present in the following documents:

• Table_2.xlsx, sheet 2

View BVdb publication page

Multi-omics data integration reveals novel drug targets in hepatocellular carcinoma.

Bmc Genomics

Dimitrakopoulos, Christos C; Hindupur, Sravanth Kumar SK; Colombi, Marco M; Liko, Dritan D; Ng, Charlotte K Y CKY; Piscuoglio, Salvatore S; Behr, Jonas J; Moore, Ariane L AL; Singer, Jochen J; Ruscheweyh, Hans-Joachim HJ; Matter, Matthias S MS; Mossmann, Dirk D; Terracciano, Luigi M LM; Hall, Michael N MN; Beerenwinkel, Niko N

Publication Date: 2021-08-04

Variant appearance in text: RUNX2: 686G>T; Arg229Leu

PubMed Link: 34348664

Variant Present in the following documents:

• Main text

View BVdb publication page